| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/27/2003 | WO2003082189A3 Method for producing pseudo islets |
| 11/27/2003 | WO2003080570A3 Recombinant expression vectors for functional nav1.9 sodium channels |
| 11/27/2003 | WO2003078613A3 Serine hydroxymethyltransferase as a target for herbicides |
| 11/27/2003 | WO2003078589A3 Method of identifying genes controlling diferentiation |
| 11/27/2003 | WO2003078580A3 Imprinting in plants to control gene expression |
| 11/27/2003 | WO2003076902A3 Multiplex detection of biological materials in a sample |
| 11/27/2003 | WO2003074723A3 Methods for detection of genetic disorders |
| 11/27/2003 | WO2003073980A3 Recombinant protein c variants |
| 11/27/2003 | WO2003072828A3 Fcgammariib polymorphisms detection in system lupus erythematosus |
| 11/27/2003 | WO2003072045A3 Treatment and prevention of aids progression and methods of using same |
| 11/27/2003 | WO2003067211A3 An improvement in a method bacterial endospore quantification using lanthanide dipicolinate luminescence |
| 11/27/2003 | WO2003064691A3 Methods and means for amplifying nucleic acid |
| 11/27/2003 | WO2003064676A3 Diagnostic and therapeutic methods using the h37 tumor suppressor gene |
| 11/27/2003 | WO2003064622A3 Aggrecanase molecules |
| 11/27/2003 | WO2003064604A3 Translation profiling |
| 11/27/2003 | WO2003062270A3 Fluorescent protein from aequorea coerulscens and uses therof |
| 11/27/2003 | WO2003061583A9 Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetes |
| 11/27/2003 | WO2003057908A3 Methods for detecting nucleic acids while using solid phase bound primers and cleaving the products of a cyclic amplification reaction (trap release primer amplification (tramp)) |
| 11/27/2003 | WO2003056329A3 Use of a signal transduction complex in drug discovery processes |
| 11/27/2003 | WO2003053338A3 Novel chimeric rev, tat, and nef antigens |
| 11/27/2003 | WO2003051901A3 Pseudonucleotide comprising an intercalator |
| 11/27/2003 | WO2003048723A3 Label-free detection of nucleic acids via surface plasmon resonance |
| 11/27/2003 | WO2003048300A3 Methods of identifying cellular target molecules |
| 11/27/2003 | WO2003048178A3 Nucleotide analogues and their use for nucleic acid sequencing |
| 11/27/2003 | WO2003046203A3 Genetic markers associated with desirable and undesirable traits in horses, methods of identifying and using such markers |
| 11/27/2003 | WO2003044214A3 Methods and compositions in checkpoint signaling |
| 11/27/2003 | WO2003043978A3 Method for selective conjugation of analytes to enzymes without unwanted enzyme-enzyme cross-linking |
| 11/27/2003 | WO2003042700A3 Breast cancer associated polypeptide |
| 11/27/2003 | WO2003040401A3 General screening method for ligand-protein interactions |
| 11/27/2003 | WO2003040397A3 Asymmetric pcr with nuclease-free polymerase or nuclease-resistant molecular beacons |
| 11/27/2003 | WO2003035906A3 Method for genotyping microsatellite dna markers by mass spectrometry |
| 11/27/2003 | WO2003031651A3 Method of determining susceptibility to inflammatory bowel disease |
| 11/27/2003 | WO2003031573A3 Toll-like receptor 3 signaling agonists and antagonists |
| 11/27/2003 | WO2003029464A3 Genes associated with mast cell activation |
| 11/27/2003 | WO2003029459A3 Micro-rna molecules |
| 11/27/2003 | WO2003027669A3 Method for producing a normalized gene library from nucleic acid extracts of soil samples and the use thereof |
| 11/27/2003 | WO2003027262A3 Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries |
| 11/27/2003 | WO2003023366A3 Method and system for classifying a scenario |
| 11/27/2003 | WO2003023354A3 Optical bio-disc systems for nuclear morphology based identification |
| 11/27/2003 | WO2003020977A3 Nucleotide repeats assay |
| 11/27/2003 | WO2003020971A3 Novel method of detecting a mutation in read phase in a coding sequence and the apparatus used to carry out same |
| 11/27/2003 | WO2003018746A3 Estrogen receptor alpha variants and methods of detection thereof |
| 11/27/2003 | WO2003017127A3 Method for modelling biochemical pathways |
| 11/27/2003 | WO2003014390A3 Screening methods and sequences relating thereto |
| 11/27/2003 | WO2003014295A3 Method and system for identifying splice variants of a gene |
| 11/27/2003 | WO2003013590A8 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 11/27/2003 | WO2003012064A3 Nucleic acids and encoded polypeptides associated with bipolar disorder |
| 11/27/2003 | WO2003010328A3 Complexity management of genomic dna |
| 11/27/2003 | WO2003010200A3 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus |
| 11/27/2003 | WO2003009100A3 Methods, apparatuses, and computer programs for verifying the integrity of a probe |
| 11/27/2003 | WO2003006995A3 Method for identifying substances which modulate interleukin 4 (il-4) signaling |
| 11/27/2003 | WO2003006611A3 GPCs AS MODIFIERS OF THE IRRTK AND p21 PATHWAYS AND METHODS OF USE |
| 11/27/2003 | WO2003004688A3 Method of genomic analysis |
| 11/27/2003 | WO2003003810A3 Methods for detection and quantification of analytes in complex mixtures |
| 11/27/2003 | WO2003003057A3 System and method for capturing multi-color fish images |
| 11/27/2003 | WO2003002979A3 Multiplex decoding of array sensors with microspheres |
| 11/27/2003 | WO2003001181A3 Detection of clonal t-cell receptor-gamma gene rearrangement by pcr/temporal temperature gradient gel electrophoresis (tige) |
| 11/27/2003 | WO2003000929A3 Polynucleotides polypeptides and cancer |
| 11/27/2003 | WO2003000927A3 Method for the determination of telomere length |
| 11/27/2003 | WO2002103046A3 Happier mapping |
| 11/27/2003 | WO2002103008A3 Templated molecules and methods for using such molecules |
| 11/27/2003 | WO2002099059A3 U5-200KDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 11/27/2003 | WO2002097075B1 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties |
| 11/27/2003 | WO2002094195A3 Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents |
| 11/27/2003 | WO2002093130A3 Methods of analyzing chromosomal translocations using fluorescence in situ hybridization (fish) |
| 11/27/2003 | WO2002092004A8 Use of hmg fragment as anti-inflammatory agents |
| 11/27/2003 | WO2002090586A3 Analytical method and kit |
| 11/27/2003 | WO2002088381A3 Method for determining gene expression |
| 11/27/2003 | WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene |
| 11/27/2003 | WO2002086113A3 Enzyme and snp marker for disease |
| 11/27/2003 | WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene |
| 11/27/2003 | WO2002083941A3 Highly specific detection system for detecting nucleotide sequences coding for lambda and kappa light chains |
| 11/27/2003 | WO2002083932A3 Enzymatic degradation chains |
| 11/27/2003 | WO2002083930A3 Immersion sensor for measuring the concentration of an analyte with the help of an oxidase |
| 11/27/2003 | WO2002081490A3 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| 11/27/2003 | WO2002077272A3 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders |
| 11/27/2003 | WO2002077164A3 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof |
| 11/27/2003 | WO2002072865A3 Methods, kits and compositions of combination oligomers |
| 11/27/2003 | WO2002072632A3 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 11/27/2003 | WO2002070006A8 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 11/27/2003 | WO2002068962A3 Determining cartilage degeneration and aging using bone morphogenic proteins |
| 11/27/2003 | WO2002066617A8 Method for detecting a risk of hypertension and uses thereof |
| 11/27/2003 | WO2002064825A3 Microelectronic array devices to perform multiplex immunoassay analysis |
| 11/27/2003 | WO2002064791A3 Proteins and nucleic acids encoding same |
| 11/27/2003 | WO2002061428A8 Method of disrupting interactions between biotin and biotin-binding compounds |
| 11/27/2003 | WO2002061140A9 Competitive population normalization for comparative analysis of nucleic acid samples |
| 11/27/2003 | WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 11/27/2003 | WO2002057499A3 Mdr1 variants and methods for their use |
| 11/27/2003 | WO2002050113A3 Interleukin-1 related gene and protein |
| 11/27/2003 | WO2002049625A3 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 11/27/2003 | WO2002048368A3 Proteins associated with cell growth, differentiation, and death |
| 11/27/2003 | WO2002010438A9 Serial analysis of transcript expression using long tags |
| 11/27/2003 | US20030221205 Olfactory and pheromones G-protein coupled receptors |
| 11/27/2003 | US20030220489 29 human secreted proteins |
| 11/27/2003 | US20030220483 Comprises fibroblast growth factor homologous factor- 1 (FHF-1) for disgnosing, prevention and treatment of neurodegenerative or neoplastic disorders |
| 11/27/2003 | US20030220306 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity |
| 11/27/2003 | US20030220281 To inhibit the activity of elastase or cathepsin G, thereby inhibiting ectopic implantation of endometrial fragments. |
| 11/27/2003 | US20030220279 Decreasing cell proliferation by decreasing levels of PP5 |
| 11/27/2003 | US20030220239 Epitope sequences |
| 11/27/2003 | US20030220232 Peptide with the sequence Gln-Tyr-Asn-Ala-Asp and derivatives differing from the original sequence by the addition, substitution, inversion, insertin, deletion or modification of one or more amino acids; sodium ion channel binder |